Notice: This company has been marked as potentially delisted and may not be actively trading. Alimera Sciences (ALIM) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Institutional Ownership Changes (13F Filings) for Alimera Sciences (NASDAQ:ALIM)CurrentInstitutional OwnershipPercentage99.83%Number ofInstitutional Buyers(last 12 months)11TotalInstitutional Inflows(last 12 months)$7.63MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$3.79M Get ALIM Insider Trade Alerts Want to know when executives and insiders are buying or selling Alimera Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ALIM Institutional Buying and Selling by Quarter Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Alimera Sciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/21/2024 Stonepine Capital Management LLC3,511,816$19.53M17.8%-13.3%6.703% 8/14/2024 Glazer Capital LLC551,533$3.07M0.2%N/A1.053% 8/14/2024 Gabelli Funds LLC108,000$600K0.0%N/A0.206% 8/9/2024 Renaissance Technologies LLC181,694$1.01M0.0%+3.9%0.347% 8/1/2024 Rhumbline Advisers20,394$113K0.0%N/A0.039% 7/26/2024 Bank of New York Mellon Corp61,907$344K0.0%N/A0.118% Get the Latest News and Ratings for ALIM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alimera Sciences and its competitors with MarketBeat's FREE daily newsletter. 7/16/2024 Deltec Asset Management LLC124,169$690K0.1%N/A0.237% 5/16/2024 Ancora Advisors LLC234,620$915K0.0%N/A0.448% 5/11/2024 Hillsdale Investment Management Inc.43,400$169K0.0%N/A0.083% 5/10/2024 Vanguard Group Inc.1,045,460$4.08M0.0%+61.1%1.996% 5/2/2024 Fifth Lane Capital LP21,238$83K0.1%N/A0.041% 2/13/2024 Stonepine Capital Management LLC3,999,459$17.28M7.5%+0.4%7.630% 2/12/2024 AIGH Capital Management LLC2,226,068$9.62M3.8%-6.2%4.247% 2/9/2024 Worth Venture Partners LLC556,642$2.41M1.3%-6.2%1.062% 11/15/2023 Worth Venture Partners LLC593,709$1.84M1.1%N/A1.133% 11/14/2023 Stonepine Capital Management LLC3,983,686$12.35M4.1%N/A7.600% 11/13/2023 AIGH Capital Management LLC2,372,572$7.36M3.5%N/A4.526% 8/14/2023 Perritt Capital Management Inc.10,000$29K0.0%-44.4%0.114% 8/11/2023 Velan Capital Investment Management LP1,659,654$4.85M4.5%+543.9%18.838% 2/16/2023 Caligan Partners LP478,777$1.30M1.0%N/A6.840% 11/15/2022 Perritt Capital Management Inc.18,000$91K0.1%-34.3%0.257% 5/12/2022 Healthcare of Ontario Pension Plan Trust Fund250,000$1.40M0.0%N/A3.575% 2/10/2022 AIGH Capital Management LLC497,639$2.55M0.8%-0.7%7.173% 11/15/2021 Ensign Peak Advisors Inc19,151$81K0.0%N/A0.276% 11/12/2021 Renaissance Technologies LLC141,588$598K0.0%-1.9%2.041% 10/22/2021 Optimum Investment Advisors8,108$34K0.0%+170.3%0.117% 8/25/2021 Marshall Wace LLP13,086$119K0.0%-50.6%0.189% 8/17/2021 Bridgeway Capital Management LLC38,300$349K0.0%+6.5%0.554% 8/16/2021 PDT Partners LLC17,723$161K0.0%+50.2%0.256% 8/16/2021 Morgan Stanley428,109$3.90M0.0%+0.7%6.190% 8/16/2021 Diametric Capital LP30,842$281K0.2%+17.1%0.446% 8/16/2021 Marshall Wace LLP13,086$119K0.0%-50.6%0.189% 8/13/2021Knott David M38,226$348K0.1%-34.2%0.553% 8/13/2021 Geode Capital Management LLC25,091$228K0.0%+14.7%0.363% 8/13/2021 Vanguard Group Inc.146,863$1.34M0.0%+16.6%2.124% 8/12/2021 Dimensional Fund Advisors LP28,570$260K0.0%N/A0.413% 8/11/2021 Deutsche Bank AG57,368$522K0.0%+51.0%0.829% 8/2/2021 Optimum Investment Advisors3,000$27K0.0%N/A0.043% 5/21/2021 Citadel Advisors LLC10,402$100K0.0%N/A0.150% 5/19/2021 Diametric Capital LP26,328$253K0.2%N/A0.381% When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away!5/18/2021 Morgan Stanley425,312$4.09M0.0%+1.1%6.150% 5/18/2021 Perritt Capital Management Inc.20,000$192K0.1%N/A0.289% 5/18/2021 Citadel Advisors LLC10,402$100K0.0%N/A0.150% 5/17/2021 PDT Partners LLC11,800$114K0.0%N/A0.171% 5/14/2021 Cooper Creek Partners Management LLC38,197$367K0.1%N/A0.552% 5/13/2021 Renaissance Technologies LLC145,213$1.40M0.0%-12.1%2.100% 5/13/2021Knott David M58,108$559K0.2%-27.5%0.840% 5/12/2021 Geode Capital Management LLC21,872$210K0.0%+57.3%0.316% 5/11/2021 Acadian Asset Management LLC16,950$163K0.0%+86.8%0.246% 2/10/2021 Renaissance Technologies LLC165,207$697K0.0%+39.3%3.219% 12/30/2020 Deerfield Management Company L.P. Series C68,413$332K0.0%N/A1.333% (Data available from 1/1/2016 forward) ALIM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ALIM shares? During the previous two years, 16 institutional investors and hedge funds held shares of Alimera Sciences. The most heavily invested institutionals were Stonepine Capital Management LLC ($19.53M), AIGH Capital Management LLC ($9.62M), Velan Capital Investment Management LP ($4.85M), Vanguard Group Inc. ($4.08M), Glazer Capital LLC ($3.07M), Worth Venture Partners LLC ($2.41M), and Caligan Partners LP ($1.30M).Learn more on ALIM's institutional investors. What percentage of Alimera Sciences stock is owned by institutional investors? 99.83% of Alimera Sciences stock is owned by institutional investors. Learn more on ALIM's institutional investor holdings. Which institutional investors have been buying Alimera Sciences stock? Of the 15 institutional investors that purchased Alimera Sciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Stonepine Capital Management LLC ($4.00M), AIGH Capital Management LLC ($2.37M), Velan Capital Investment Management LP ($1.40M), Worth Venture Partners LLC ($593.71K), Glazer Capital LLC ($551.53K), Caligan Partners LP ($478.78K), and Vanguard Group Inc. ($396.51K). How much institutional buying is happening at Alimera Sciences? Institutional investors have bought a total of 10,415,085 shares in the last 24 months. This purchase volume represents approximately $34.57M in transactions. Which Alimera Sciences major shareholders have been selling company stock? The following institutional investors have sold Alimera Sciences stock in the last 24 months: Stonepine Capital Management LLC ($539.26K), AIGH Capital Management LLC ($146.50K), Worth Venture Partners LLC ($37.07K), and Perritt Capital Management Inc. ($8K). How much institutional selling is happening at Alimera Sciences? Institutional investors have sold a total of 730,827 shares in the last 24 months. This volume of shares sold represents approximately $3.81M in transactions. Related Companies MESO Institutional Ownership GYRE Institutional Ownership APLT Institutional Ownership AVDL Institutional Ownership COGT Institutional Ownership BCAX Institutional Ownership COLL Institutional Ownership ZYME Institutional Ownership BCYC Institutional Ownership PAHC Institutional Ownership This page (NASDAQ:ALIM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alimera Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alimera Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
